FRANCE’S SANOFI HALTS TRIALS OF FAILED COVID-19 DRUG
Tue 01 September 2020: PARIS – French pharmaceutical company Sanofi announced Tuesday that it was halting clinical trials of its drug Kevzara for use against the novel coronavirus. Recent international clinical trials conducted with the drug — typically used for rheumatoid arthritis — have produced adverse reactions in some patients, including pneumonia and even death. […]
Continue Reading
